BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37579831)

  • 1. Spatial distribution and functional relevance of FGFR1 and FGFR2 expression for glioblastoma tumor invasion.
    Alshahrany N; Begum A; Siebzehnrubl D; Jimenez-Pascual A; Siebzehnrubl FA
    Cancer Lett; 2023 Sep; 571():216349. PubMed ID: 37579831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
    André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
    Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth.
    Tarkkonen KM; Nilsson EM; Kähkönen TE; Dey JH; Heikkilä JE; Tuomela JM; Liu Q; Hynes NE; Härkönen PL
    PLoS One; 2012; 7(11):e49970. PubMed ID: 23185502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury.
    House SL; Castro AM; Lupu TS; Weinheimer C; Smith C; Kovacs A; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2016 Mar; 310(5):H559-71. PubMed ID: 26747503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer.
    Moes-Sosnowska J; Skupinska M; Lechowicz U; Szczepulska-Wojcik E; Skronska P; Rozy A; Stepniewska A; Langfort R; Rudzinski P; Orlowski T; Popiel D; Stanczak A; Wieczorek M; Chorostowska-Wynimko J
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of glioblastoma cell growth following antisense oligonucleotide-mediated inhibition of fibroblast growth factor receptor expression.
    Yamada SM; Yamaguchi F; Brown R; Berger MS; Morrison RS
    Glia; 1999 Oct; 28(1):66-76. PubMed ID: 10498824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
    Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
    World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function.
    Pond AC; Bin X; Batts T; Roarty K; Hilsenbeck S; Rosen JM
    Stem Cells; 2013 Jan; 31(1):178-89. PubMed ID: 23097355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
    Erber R; Rübner M; Davenport S; Hauke S; Beckmann MW; Hartmann A; Häberle L; Gass P; Press MF; Fasching PA
    Breast Cancer Res Treat; 2020 Nov; 184(2):311-324. PubMed ID: 32852708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR1 Induces Glioblastoma Radioresistance through the PLCγ/Hif1α Pathway.
    Gouazé-Andersson V; Delmas C; Taurand M; Martinez-Gala J; Evrard S; Mazoyer S; Toulas C; Cohen-Jonathan-Moyal E
    Cancer Res; 2016 May; 76(10):3036-44. PubMed ID: 26896280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models.
    Guffanti F; Chilà R; Bello E; Zucchetti M; Zangarini M; Ceriani L; Ferrari M; Lupi M; Jacquet-Bescond A; Burbridge MF; Pierrat MJ; Damia G
    Neoplasia; 2017 Jan; 19(1):35-42. PubMed ID: 27988457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.
    Sahadevan K; Darby S; Leung HY; Mathers ME; Robson CN; Gnanapragasam VJ
    J Pathol; 2007 Sep; 213(1):82-90. PubMed ID: 17607666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
    Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
    Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
    Feng S; Wang F; Matsubara A; Kan M; McKeehan WL
    Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer.
    Cheng CL; Thike AA; Tan SY; Chua PJ; Bay BH; Tan PH
    Breast Cancer Res Treat; 2015 May; 151(1):99-111. PubMed ID: 25868865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ureteric morphogenesis requires Fgfr1 and Fgfr2/Frs2α signaling in the metanephric mesenchyme.
    Sims-Lucas S; Di Giovanni V; Schaefer C; Cusack B; Eswarakumar VP; Bates CM
    J Am Soc Nephrol; 2012 Apr; 23(4):607-17. PubMed ID: 22282599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma.
    Tsimafeyeu I; Demidov L; Stepanova E; Wynn N; Ta H
    Scand J Urol Nephrol; 2011 Apr; 45(3):190-5. PubMed ID: 21329481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrations in
    Kelam N; Racetin A; Polović M; Benzon B; Ogorevc M; Vukojević K; Glavina Durdov M; Dunatov Huljev A; Kuzmić Prusac I; Čarić D; Raguž F; Kostić S
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.